WASHINGTON, Dec. 20 -- The House Energy and Commerce Subcommittee on Health issued the following testimony by Amy Abernethy, president of clinical studies platforms of Verily Life Sciences, involving a hybrid hearing on Dec. 8, 2021, entitled "The Next Frontier: Translating Biomedical Research into Personalized Health Care":

* * *

Chairwoman Eshoo, Ranking Member Guthrie, and members of the Health Subcommittee, thank you for inviting me to testify on a very im . . .

Click here for more information about our products